The microfluidic multiplex biosensor carries proteins attached to a polymer film that recognize the antibiotics.
Photo: Patrick Seeger
Freiburg researchers are testing a biosensor for personalized dosing of medications.
A team of engineers and biotechnologists at the University of Freiburg has for the first time shown in mammals that the concentration of antibiotics in the body can be determined using breath samples. The breath measurements also corresponded to the antibiotic concentrations in the blood. The team’s biosensor – a multiplex chip that allows simultaneous measurement of several specimens and test substances – will in future enable personalized dosing of medicines against infectious diseases on-site and help to minimize the development of resistant strains of bacteria.
The sensor developed by the research group headed by Dr. Can Dincer and H. Ceren Ates, FIT Freiburg Center for Interactive Materials and Bioinspired Technologies, and Prof. Dr. Wilfried Weber, Professor of Synthetic Biology and a member of the team of speakers at the Cluster of Excellence CIBSS – Centre for Integrative Biological Signalling Studies, is based on synthetic proteins that react to antibiotics and thus generate a current change. The researchers’ results are now being published in the journal Advanced Materials.
Previously researchers could only detect traces of antibiotics in the breath
The researchers tested the biosensor on the blood, plasma, urine, saliva and breath samples of pigs who had received antibiotics. They were able to show that the result achieved with biosensors in the pigs’ plasma were as accurate as the standard medical laboratory process. Previously, measurement of antibiotic levels in exhaled breath samples was not possible: “Until now researchers could only detect traces of antibiotics in the breath. With our synthetic proteins on a microfluidic chip, we can determine the smallest concentrations in the breath condensate and they correlate with the blood values,” explains Dincer.
Sensor will help to keep antibiotic level stable in severely ill
Physicians need to keep the antibiotics level within a personalized therapeutic range for patients suffering severe infections, at the risk of threats such as sepsis and organ failure or even the death of the patient. Inadequate administration of antibiotics could allow bacteria to mutate so that the medicines no longer work: they become resistant. “Rapid monitoring of antibiotic levels would be a huge advantage in hospital,” says Ates, “it might be possible to fit the method into a conventional face mask.” In another project at the University of Freiburg, Dincer is developing wearable paper sensors for the continuous measurement of biomarkers from exhaled breath. Clinical trials to validate the antibiotic biosensor by testing the system with human samples are planned.
Bacterial proteins as sensor
The microfluidic biosensor bears proteins that can recognize beta-lactam antibiotics such as penicillin, affixed to a polymer film. Antibiotic of interest in the sample and an enzyme-coupled beta-lactam are in competition to bind these bacterial proteins. This competition generates a current change – like in a battery: the more antibiotic there is present in the sample, the less enzyme product develops, which leads to a lower measurable current. The process is based on a natural receptor protein that resistant bacteria uses to detect the antibiotics that threatens them. “You could say we are beating the bacteria at their own game,” Weber says of the process developed by his group.
Original Article: Antibiotic levels measurable in breath for first time
More from: University of Freiburg
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Microfluidic multiplex biosensor
- Molecular Diagnostics 2018on July 27, 2022 at 5:00 pm
Our 3 rd Annual Molecular Diagnostics Virtual Conference is now available On Demand! The Molecular Diagnostics Event is the premiere venue for scientists, technologists, and professionals to discuss ...
- Molecular Diagnostics 2018on July 27, 2022 at 5:00 pm
Our 3 rd Annual Molecular Diagnostics Virtual Conference is now available On Demand! The Molecular Diagnostics Event is the premiere venue for scientists, technologists, and professionals to discuss ...
- Biosensors & bioelectronicson July 2, 2022 at 5:00 pm
A wearable battery-free wireless and skin-interfaced microfluidics integrated ... Surface plasmon resonance imaging-based biosensor for multiplex and ultrasensitive detection of NSCLC-associated ...
- S-1: NANOMIX Corpon June 21, 2022 at 5:35 pm
Nanomix Corp. 2121 Williams St. San Leandro, CA 94577 (510) 428-5300 (Address and telephone number of registrant's principal executive offices) David Ludvigson Nanomix Corp. Chief Executive ...
- IBIS-MX96 Microfluidic System from Wasatchon June 16, 2022 at 5:00 pm
The Instrument for Biomolecular Interaction Sensing MultipleX 96 (IBIS-MX96) is a comprehensive system for multiplex biomolecular interaction imaging. The MX96 is optimized for monitoring 96 ...
Go deeper with Google Headlines on:
Microfluidic multiplex biosensor
Go deeper with Bing News on:
Microfluidic biosensor
- EDAN Launches Next-Gen ABG Solutions for the Clinic During 2022 AACCon July 26, 2022 at 10:18 am
A lightweight POC CO-oximetry blood gas and chemistry system i20 reveals how photoluminescence biosensor coupled with microfluidics could transform the future of ABG tests in clinical departments.
- EDAN Launches Next-Gen ABG Solutions for the Clinic During 2022 AACCon July 26, 2022 at 8:47 am
A lightweight POC CO-oximetry blood gas and chemistry system i20 reveals how photoluminescence biosensor coupled with microfluidics could transform the future of ABG tests in clinical departments.
- Biosensor Market Analysis by Key Type and Applications, Industry Growth Factors and Business Forecast 2027on July 26, 2022 at 6:29 am
Wearable biosensor applications help change centralized ... Deficiency Market Research Report—Forecast till 2027 Global Microfluidics Device Market Research Report -Forecast to 2027 Global ...